132 related articles for article (PubMed ID: 11719453)
21. ImmTAC-redirected tumour cell killing induces and potentiates antigen cross-presentation by dendritic cells.
Bossi G; Buisson S; Oates J; Jakobsen BK; Hassan NJ
Cancer Immunol Immunother; 2014 May; 63(5):437-48. PubMed ID: 24531387
[TBL] [Abstract][Full Text] [Related]
22. Bacteria-induced gap junctions in tumors favor antigen cross-presentation and antitumor immunity.
Saccheri F; Pozzi C; Avogadri F; Barozzi S; Faretta M; Fusi P; Rescigno M
Sci Transl Med; 2010 Aug; 2(44):44ra57. PubMed ID: 20702856
[TBL] [Abstract][Full Text] [Related]
23. [Effect of tumor antigen released during photodynamic therapy or freezing-thawing on the maturation phenotypes of dendritic cells].
Jiang S; Xia YM; Cheng D; Cheng H
Zhonghua Yi Xue Za Zhi; 2011 Jan; 91(2):121-4. PubMed ID: 21418996
[TBL] [Abstract][Full Text] [Related]
24. Preclinical exploration of combining plasmacytoid and myeloid dendritic cell vaccination with BRAF inhibition.
Tel J; Koornstra R; de Haas N; van Deutekom V; Westdorp H; Boudewijns S; van Erp N; Di Blasio S; Gerritsen W; Figdor CG; de Vries IJ; Hato SV
J Transl Med; 2016 Apr; 14():88. PubMed ID: 27075584
[TBL] [Abstract][Full Text] [Related]
25. Cell surface externalization of annexin A1 as a failsafe mechanism preventing inflammatory responses during secondary necrosis.
Blume KE; Soeroes S; Waibel M; Keppeler H; Wesselborg S; Herrmann M; Schulze-Osthoff K; Lauber K
J Immunol; 2009 Dec; 183(12):8138-47. PubMed ID: 20007579
[TBL] [Abstract][Full Text] [Related]
26. The effects of zoledronate on monocyte-derived dendritic cells from melanoma patients differ depending on the clinical stage of the disease.
Failli A; Legitimo A; Orsini G; Romanini A; Consolini R
Hum Vaccin Immunother; 2014; 10(11):3375-82. PubMed ID: 25483657
[TBL] [Abstract][Full Text] [Related]
27. Dermis-derived stem cells: a source of epidermal melanocytes and melanoma?
Zabierowski SE; Fukunaga-Kalabis M; Li L; Herlyn M
Pigment Cell Melanoma Res; 2011 Jun; 24(3):422-9. PubMed ID: 21410654
[TBL] [Abstract][Full Text] [Related]
28. The immune escape in melanoma: role of the impaired dendritic cell function.
Tucci M; Stucci S; Passarelli A; Giudice G; Dammacco F; Silvestris F
Expert Rev Clin Immunol; 2014 Oct; 10(10):1395-404. PubMed ID: 25225774
[TBL] [Abstract][Full Text] [Related]
29. Presence and phenotype of dendritic cells in uveal melanoma.
Polak ME; Borthwick NJ; Johnson P; Hungerford JL; Higgins B; Di Palma S; Jager MJ; Cree IA
Br J Ophthalmol; 2007 Jul; 91(7):971-6. PubMed ID: 17347328
[TBL] [Abstract][Full Text] [Related]
30. Early Tumor-Infiltrating Dendritic Cells Change their Characteristics Drastically in Association with Murine Melanoma Progression.
Nakahara T; Oba J; Shimomura C; Kido-Nakahara M; Furue M
J Invest Dermatol; 2016 Jan; 136(1):146-53. PubMed ID: 26763434
[TBL] [Abstract][Full Text] [Related]
31. [Melanoma: surface markers as the first point of targeted delivery of therapeutic genes in multilevel gene therapy].
Pleshkan VV; Zinov'eva MV; Sverdlov ED
Mol Biol (Mosk); 2011; 45(3):416-33. PubMed ID: 21790004
[TBL] [Abstract][Full Text] [Related]
32. Poly(I:C)-induced tumour cell death leads to DC maturation and Th1 activation.
Kovalcsik E; Lowe K; Fischer M; Dalgleish A; Bodman-Smith MD
Cancer Immunol Immunother; 2011 Nov; 60(11):1609-24. PubMed ID: 21691724
[TBL] [Abstract][Full Text] [Related]
33. A lactate-SREBP2 signaling axis drives tolerogenic dendritic cell maturation and promotes cancer progression.
Plebanek MP; Xue Y; Nguyen YV; DeVito NC; Wang X; Holtzhausen A; Beasley GM; Theivanthiran B; Hanks BA
Sci Immunol; 2024 May; 9(95):eadi4191. PubMed ID: 38728412
[TBL] [Abstract][Full Text] [Related]
34. Release of iC3b from apoptotic tumor cells induces tolerance by binding to immature dendritic cells in vitro and in vivo.
Schmidt J; Klempp C; Büchler MW; Märten A
Cancer Immunol Immunother; 2006 Jan; 55(1):31-8. PubMed ID: 15891882
[TBL] [Abstract][Full Text] [Related]
35. Platelet P-selectin initiates cross-presentation and dendritic cell differentiation in blood monocytes.
Han P; Hanlon D; Arshad N; Lee JS; Tatsuno K; Robinson E; Filler R; Sobolev O; Cote C; Rivera-Molina F; Toomre D; Fahmy T; Edelson R
Sci Adv; 2020 Mar; 6(11):eaaz1580. PubMed ID: 32195350
[TBL] [Abstract][Full Text] [Related]
36. A role for CD36 in the regulation of dendritic cell function.
Urban BC; Willcox N; Roberts DJ
Proc Natl Acad Sci U S A; 2001 Jul; 98(15):8750-5. PubMed ID: 11447263
[TBL] [Abstract][Full Text] [Related]
37. What do we mean when we write "senescence," "apoptosis," "necrosis," or "clearance of dying cells"?
Mevorach D; Trahtemberg U; Krispin A; Attalah M; Zazoun J; Tabib A; Grau A; Verbovetski-Reiner I
Ann N Y Acad Sci; 2010 Oct; 1209():1-9. PubMed ID: 20958309
[TBL] [Abstract][Full Text] [Related]
38. Inhibitor of Apoptosis Proteins Antagonist Induces T-cell Proliferation after Cross-Presentation by Dendritic Cells.
Hoefsmit EP; van Royen PT; Rao D; Stunnenberg JA; Dimitriadis P; Lieftink C; Morris B; Rozeman EA; Reijers ILM; Lacroix R; Shehwana H; Ligtenberg MA; Beijersbergen RL; Peeper DS; Blank CU
Cancer Immunol Res; 2023 Apr; 11(4):450-465. PubMed ID: 36753604
[TBL] [Abstract][Full Text] [Related]
39. Branched Polyethylenimine-Superparamagnetic Iron Oxide Nanoparticles (bPEI-SPIONs) Improve the Immunogenicity of Tumor Antigens and Enhance Th1 Polarization of Dendritic Cells.
Hoang MD; Lee HJ; Lee HJ; Jung SH; Choi NR; Vo MC; Nguyen-Pham TN; Kim HJ; Park IK; Lee JJ
J Immunol Res; 2015; 2015():706379. PubMed ID: 26221615
[TBL] [Abstract][Full Text] [Related]
40. The Uptake of Extracellular Vesicles is Affected by the Differentiation Status of Myeloid Cells.
Czernek L; Chworos A; Duechler M
Scand J Immunol; 2015 Dec; 82(6):506-14. PubMed ID: 26332303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
